• Sectors we work in banner(2)

    Quick Reads

Overseas investors in Life Sciences set to be caught by new beneficial ownership reporting regime

Overseas investors flooding into the Life Sciences sector should be aware of the imminent impact of the Economic Crime (Transparency and Enforcement) Act 2022 (ECA), which received Royal Assent on 15 March 2022.  The ECA will establish a register of overseas entities (ROE) who own real estate in the UK, requiring the disclosure of information about the beneficial ownership of that entity. That requirement will go "right up the chain" until the ultimate beneficial ownership of an entity is identified. This will be a public register, maintained by Companies House and any entity seeking to register an interest at the Land Registry (or to deal with an existing interest) must first be on the ROE.

"Overseas entities" are defined in the ECA as legal entities governed by the law of a country or territory outside the UK.  Any such overseas entity must register if: 

(i) they already own a "qualifying estate", which in England and Wales is defined as a freehold interest or a leasehold estate for a term of more than seven years and were registered at the Land Registry on or after 1 January 1999; and/or 

(ii) if they propose to buy, let or sell a qualifying estate in the future.

Once registered, an Overseas Entity ID (OEID) will be issued, which will be required for all dealings at the Land Registry.  Once the ECA comes into force, the Land Registry will impose a restriction on the title of all qualifying estates owned by an overseas entity.  That restriction will effectively prohibit any sale, purchase, lease or charge of that qualifying estate until the relevant entity has an OEID.  If the relevant entity has not applied for an OEID within six months of the registration of that restriction, an offence will have been committed, potentially subjecting the company officers to a fine or imprisonment.  

In addition to the initial obligation to register for an OEID, the relevant entity will also need to comply with updating obligations at least every 12 months in order to maintain a valid OEID. 

Further detail of the proposals can be found here, but we expect the ECA to come into force quickly, following recent political pressure to understand land ownership in the UK following the invasion of Ukraine by Russia.  

With Life Sciences transactions being typically fast-moving given the ongoing buoyancy in the market, overseas entities will need to act promptly to ensure they are able to meet the requirements to enable them to transact in the post-ECA climate.

Our new Register of Overseas Entities, the first of its kind in the world, will have an immediate dissuasive effect on oligarchs attempting to hide their ill-gotten gains, ensuring that the UK is a place for legitimate business only.

Our thinking

  • Planning and Life Sciences: the challenges and opportunities in the Golden Triangle

    Sophie Willis

    Quick Reads

  • London’s Knowledge Clusters: From Emerging to Maturing – Start Ups on the Global Stage?

    Lynsey Inglis

    Quick Reads

  • Charles Russell Speechlys hosts international arbitration event in Dubai

    Peter Smith

    Quick Reads

  • Re-purposing Retail - is life sciences the answer?

    Louise Ward

    Quick Reads

  • EG quotes Louise Ward on Labour’s strategy for the Life Sciences sector

    Louise Ward

    In the Press

  • EU AI Act – Will it become a law for all the world?

    Nick White

    Quick Reads

  • Court of Appeal Confirms that Property Guardians Occupied an HMO

    Christopher Gothard

    Quick Reads

  • BE News quotes Louise Ward on the Autumn Statement and life sciences support

    Louise Ward

    In the Press

  • Property Week quotes Louise Ward on the additional support required by aspiring UK life sciences operators

    Louise Ward

    In the Press

  • Office to Lab Conversions: A new lease of life (sciences) for some of London’s offices?

    Quick Reads

  • EG quotes Louise Ward on the lack of supply of quality life sciences real estate

    Louise Ward

    In the Press

  • Louise Ward writes for Property Week on ESG challenges in life sciences real estate

    Louise Ward

    In the Press

  • Pharmaphorum quotes Louise Ward on the Budget and what this means for the biopharma sector

    Louise Ward

    In the Press

  • Life Sciences blow as AZ snubs UK

    Louise Ward

    Quick Reads

  • Property Patter: Life Sciences

    Louise Ward

    Podcasts

  • EG quotes Louise Ward on the resilience of the life sciences sector in 2022

    Louise Ward

    In the Press

  • Life Sciences - Where Next?

    Fiona Edmond

    Quick Reads

  • Part 2: The Tip of the Triangle – Taking advantage of London’s potential in the Life Sciences Sector

    Lynsey Inglis

    Quick Reads

  • Part 1: The Tip of the Triangle – Examining London’s Potential in the Life Sciences Sector

    Amy Shuttleworth

    Quick Reads

  • Construction and the Multimodal Approach in the Life Sciences Industry

    Fiona Edmond

    Quick Reads

Back to top